China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 12 full market research reports on lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs. These new studies examine China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.